NFR-CS: The Nociceptive Flexion Reflex as a Diagnostic Tool of Central Sensitization

Sponsor
University Ghent (Other)
Overall Status
Recruiting
CT.gov ID
NCT05321550
Collaborator
(none)
240
1
18
13.3

Study Details

Study Description

Brief Summary

This experimental study will investigate whether the decreased NFR threshold and increased NFR temporal summation, which are frequently observed in chronic pain patients, are only symptomatic manifestations that occur in the involved limb and indicate peripheral sensitization or generalized manifestations that are also present in the non-involved limbs and thus indicate central sensitization. To gain an idea of the presence of central sensitization, this study will also investigate whether there are increased perception and decreased pain thresholds in response to electrical, thermal, and mechanical stimulation, as well as whether there is a decreased conditioned pain modulation. To investigate this, it is essential to examine different pain populations and locations, in particular, acute pain versus chronic pain populations to compare peripheral versus central sensitization, respectively. Recently, our research group has shown that patients with a traumatic origin of chronic neck pain (chronic whiplash-associated disorders) show central sensitization in contrast to patients with a non-traumatic origin (chronic idiopathic neck pain) who demonstrate only indications for peripheral sensitization. Therefore, this study will also distinguish between complaints of traumatic and non-traumatic origin.

The measurements will be performed at different locations, namely the lower and upper limbs. To determine whether the differences depend on the measurement location (= location where experimental nociceptive stimulation is administered) and symptom location (= location of clinical nociceptive stimulation), different patient populations will be compared with each other, as well as with a healthy control population. In acute and chronic whiplash patients and patients with acute and chronic idiopathic neck pain complaints, the complaints are primarily localized in the upper limb. It is hypothesized that in chronic neck pain patients (both whiplash and idiopathic neck pain patients) abnormal values are found in both the upper and lower limbs compared to the healthy controls due to central sensitization. In acute neck pain patients (both whiplash and idiopathic neck pain) only abnormal values in the arm are expected and not in the leg as a result of peripheral sensitization. It is hypothesized that patients with neck pain of traumatic origin will show a stronger sensitization than those with neck pain of non-traumatic origin. In acute and chronic low back pain patients, the complaints are primarily localized in the lower body quadrant. As a result of central sensitization in the chronic low back pain patients, abnormal values are expected in both the upper and lower limbs, while only abnormal values in the leg are expected as a result of peripheral sensitization in the acute low back pain patients. Finally, this study will investigate whether chronic low back and neck pain patients show a similar pattern of central sensitization as fibromyalgia patients, a population with generalized complaints that are primarily attributed to central sensitization.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    240 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Cross-Sectional
    Official Title:
    De Nociceptieve Flexie Reflex Als Diagnostische Test Voor Centrale Sensitisatie
    Anticipated Study Start Date :
    Apr 1, 2022
    Anticipated Primary Completion Date :
    Oct 1, 2023
    Anticipated Study Completion Date :
    Oct 1, 2023

    Arms and Interventions

    Arm Intervention/Treatment
    Fibromyalgia patients

    Fibromyalgia patients diagnosed according to the 2010 ACR-criteria

    Neck pain patients

    Patients with non-specific, idiopathic neck pain complaints Patients with neck pain complaints of traumatic origin type whiplash grade 1 (pain, stiffness or tenderness of the neck and no objective physical abnormalities) and grade 2 (neck complaints and musculoskeletal disorders such as reduced range of motion and tender pain points) according to the Quebec Task Force on Whiplash Associated Disorders

    Low back pain patients

    Patients with non-specific, idiopathic back pain complaints

    Healthy controls

    Age, sex and BMI-matched healthy controls

    Outcome Measures

    Primary Outcome Measures

    1. Quantitative sensory testing (QST) - electrical detection threshold [Baseline]

      Determination of sensory detection thresholds in response to electrical stimuli which are delivered transcutaneously over the n. suralis and n. medianus, recorded in mA.

    2. Quantitative sensory testing (QST) - electrical pain threshold [Baseline]

      Determination of sensory pain threshold in response to electrical stimuli which are delivered transcutaneously over the n. suralis and n. medianus, recorded in mA.

    3. Quantitative sensory testing (QST) - thermal detection threshold [Baseline]

      Determination of sensory detection thresholds in response to thermal stimuli which are delivered to the skin using a thermode, recorded in °C: cold detection threshold warmth detection threshold

    4. Quantitative sensory testing (QST) - thermal pain threshold [Baseline]

      Determination of sensory pain thresholds in response to thermal stimuli which are delivered to the skin using a thermode, recorded in °C: cold pain threshold heat pain threshold

    5. Quantitative sensory testing (QST) - discrimination between thermal stimuli [Baseline]

      Determination of the number of paradoxical heat sensations in response to alternating cold and warm stimuli delivered to the skin using a thermode.

    6. Quantitative sensory testing (QST) - tactile detection threshold [Baseline]

      Determination of tactile detection threshold, assessed using Von Frey monofilaments, recorded in mN

    7. Quantitative sensory testing (QST) - mechanical pain threshold [Baseline]

      Determination of mechanical pain threshold, assessed using pinprick stimulators, recorded in mN

    8. Quantitative sensory testing (QST) - sensitivity to pressure stimuli [Baseline]

      Determination of pressure pain threshold, assessed using pressure algometry, recorded in kg

    9. Quantitative sensory testing (QST) - temporal summation of electrical stimuli [Baseline]

      Determination of temporal summation in response to electrical stimuli delivered transcutaneously over the skin of the n. suralis and n. medianus. The numerical pain rating in response to these stimuli (range 0 - 100) will be recorded.

    10. Quantitative sensory testing (QST) - spinal hyperexcitability [Baseline]

      Determination of spinal hyperexcitability using the nociceptive flexion reflex (NFR; sensitization of spinal cord neurons), recorded in mA

    11. Quantitative sensory testing (QST) - temporal summation of spinal hyperexcitability [Baseline]

      Determination of temporal summation of the nociceptive flexion reflex (NFR; sensitization of spinal cord neurons), recorded using a numeric pain rating scale (range 0 - 100)

    12. Quantitative sensory testing - conditioned pain modulation [Baseline]

      Determination of condition pain modulation (aka. pain inhibits pain) by means of a heterotopic noxious counterstimulation paradigm. Test stimuli comprise of pressure pain threshold assessments and application of a heat stimulus (using a thermode) corresponding to a temperature eliciting a visual analog scale rating of 5/10. Test stimuli will be applied before, during and after the conditioning stimulus which is the immersion of the hand in a hot circulating water bath of 45.5°C.

    Secondary Outcome Measures

    1. Central sensitization inventory [Baseline]

      Self-report measure of signs and symptoms associated with central sensitization

    2. Douleur Neuropathique 4 Questionnaire [Baseline]

      Clinician administered questionnaire for evaluation of signs and symptoms associated with neuropathic pain

    3. Pain catastrophizing scale [Baseline]

      Self-report measure of pain perceptions and cognitions

    4. Pain vigilance and awareness questionnaire [Baseline]

      Self-report measure assessing preoccupation with and attention to pain

    5. Tampa scale for kinesiophobia [Baseline]

      Self-report measure assessing fear of movement

    6. International physical activity questionnaire [Baseline]

      Self-report measure of physical activity in preceeding 7 days

    7. Patient-reported outcomes measurement information system - physical functioning [Baseline]

      Self-report measure of health-related domains relating to physical functioning

    8. Patient-reported outcomes measurement information system - anxiety [Baseline]

      Self-report measure of health-related domains relating to anxiety

    9. Patient-reported outcomes measurement information system - depression [Baseline]

      Self-report measure of health-related domains relating to depression

    10. Patient-reported outcomes measurement information system - fatigue [Baseline]

      Self-report measure of health-related domains relating to fatigue and sleep disruption

    11. Patient-reported outcomes measurement information system - participation [Baseline]

      Self-report measure of health-related domains relating to participation in social activities

    12. Patient-reported outcomes measurement information system - pain interference [Baseline]

      Self-report measure of health-related domains relating to pain interference

    13. Injustice Experience Questionnaire [Baseline]

      Self-report measure of perceived injustice

    14. Pain Disability Index [Baseline]

      Self-report measure of pain-related disability

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria Fibromyalgia patients:
    • diagnosed according to 2010 ACR-criteria
    Inclusion Criteria neck pain patients:
    • having idiopathic neck pain complaints or having grade 1 (pain, stiffness or tenderness of the neck and without objective physical abnormalities) or grade 2 (neck complaints and musculoskeletal disorders such as decreased range of motion and tender pain points) according to the Quebec Task Force on Whiplash Associated Disorders
    Inclusion Criteria low back pain patients:
    • having idiopathic low back pain complaints
    Inclusion Criteria healthy controls:
    • no history of serious pain complaints (e.g. severe migraine, fibromyalgia, etc.)

    • no low back or neck pain complaints with an intensity of ≥2/10 on a visual analogue scale in the past year and of such severity that the daily activities were disrupted and a (para)medic was consulted

    Exclusion Criteria:
    • history of severe respiratory (e.g. cystic fibrosis), orthopedic (e.g. whiplash trauma), neurological (e.g. cerebrovascular incident), cardiovascular (e.g. severe hypertension), or endocrinological (e.g. diabetes) disorders

    • recent psychological trauma (e.g. post-traumatic stress disorder)

    • history of spinal surgery (e.g. lumbar discectomy), spinal trauma (e.g. vertebral fracture), or severe spinal deformities (e.g. spondylolisthesis)

    • BMI ≥35 (due to potential difficulties in obtaining an NFR in severely overweight individuals)

    • having pacemakers and defibrillators (absolute exclusion criteria for electrical stimulus stimulation, i.e. TENS)

    • pregnancy, lactation, or within 1 year postpartum

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Ghent University Ghent Belgium

    Sponsors and Collaborators

    • University Ghent

    Investigators

    • Principal Investigator: Jessica Van Oosterwijck, University Ghent

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Ghent
    ClinicalTrials.gov Identifier:
    NCT05321550
    Other Study ID Numbers:
    • BC-5159
    First Posted:
    Apr 11, 2022
    Last Update Posted:
    Apr 28, 2022
    Last Verified:
    Mar 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 28, 2022